People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Other, Other Technology, Biotech / Pharma, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Netpreme Corp | — | Other | Series A | $11.9M | $39.4M | 2025 |
| Brelyon Inc. | — | Other Technology | Series A | $11.5M | $151.8M | 2022 |
| Maniro Inc. | — | Other Technology | Series A | $9.9M | $51.7M | 2024 |
| Fieldstone Bio, Inc. | — | Biotech / Pharma | Series A | $5.9M | $24.8M | 2024 |
| DxLab Inc. | — | Other Health Care | Seed | $4.0M | $81.4M | 2020 |
Calvin Chin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Calvin Chin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ed Sim | 1 | 7 |
| JEONG SEUK KANG | 1 | 4 |
| Adam Mullinax | 1 | 3 |
| Samuel Prentice | 1 | 2 |
| Fahim Farzadfard | 1 | 2 |
| Patrick Stone | 1 | 1 |
| Brandon Fields | 1 | 1 |
| Nikita Lazarev | 1 | 1 |
| Ruijie He | 1 | 1 |
| Zhizhen Zhong | 1 | 1 |
| Shenggao Li | 1 | 1 |
| Ho-Jun Suk | 1 | 1 |
| Alok Mehta | 1 | 1 |
| Barmak Heshmat Dekhordi | 1 | 1 |
| Yuqin Duan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.